UK Biotech Booms But Will It Ever Produce A Big Player?
Investment From US On The Rise
Any chance that Kymab would advance to become a fully integrated biopharma has gone with Sanofi's deep pockets turning the heads of investors. Is the UK ever likely to develop its own Amgen or Moderna?
